Evome Medical Technologies Inc. (LNDZF)
| Previous Close | 0.0000 |
| Open | 0.1000 |
| Bid | 0.0400 x 0 |
| Ask | 0.2230 x 0 |
| Day's Range | 0.1000 - 0.1000 |
| 52 Week Range | 0.0111 - 0.2100 |
| Volume | |
| Avg. Volume | 1,252 |
| Market Cap | 8.545M |
| Beta (5Y Monthly) | 1.90 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1800 |
| Earnings Date | Nov 12, 2024 - Nov 16, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | May 24, 2017 |
| 1y Target Est | N/A |
- GlobeNewswire
Evome Medical Technologies Reviews Highlights of Low-CapEx Revenue Growth Plan
Posts updated corporate presentation to website Reminder: Conference call to be held on August 19th to discuss Q2 2024 financial results SHIRLEY, N.Y., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) highlights its low-CapEx plan for growing revenue in an updated corporate presentation now available at www.evomemedical.com/investor. The presentation, to be used during investor meetings planned for next month in New York, Vancouver, Montre
- GlobeNewswire
Evome Medical Technologies Reports Second Quarter 2024 Financial Results
Stabilizes business with a return to positive Adjusted EBITDAPromotes Gordon Bean to Chief Financial OfficerAnnounces August 19th conference call to discuss financial results SHIRLEY, N.Y., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) today reported financial results for the second quarter ended June 30, 2024, featuring $421,000 in positive Adjusted EBITDA1, a reduction in debt, financial performance momentum and significant progress
- GlobeNewswire
Evome Medical Technologies Retains irlabs for Investor Relations Services
NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) is pleased to announce it has entered into an agreement ("Agreement") with IR Labs Inc. ("irlabs") to provide the Company with investor relations and communications services. “We look forward to this partnership with irlabs as we work to raise our profile in the investment community,” said Mike Seckler, CEO. “In tandem with their expert team, we’re confident we can amplify our stor
